Anna Sandberg

756 total citations
46 papers, 453 citations indexed

About

Anna Sandberg is a scholar working on Information Systems, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Anna Sandberg has authored 46 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Information Systems, 13 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Surgery. Recurrent topics in Anna Sandberg's work include Diabetes Treatment and Management (12 papers), Software Engineering Techniques and Practices (11 papers) and Software Engineering Research (9 papers). Anna Sandberg is often cited by papers focused on Diabetes Treatment and Management (12 papers), Software Engineering Techniques and Practices (11 papers) and Software Engineering Research (9 papers). Anna Sandberg collaborates with scholars based in Sweden, Denmark and United States. Anna Sandberg's co-authors include Lars Pareto, Thomas Arts, Miroslaw Staron, Lars Mathiassen, Annie Nikolajsen, Pierre Johansen, Amos Db, Moore Ge, Matthew Capehorn and Sarah Buchs and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes and Computer.

In The Last Decade

Anna Sandberg

41 papers receiving 429 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Sandberg Sweden 13 135 118 71 51 45 46 453
R.J.M. Ross United Kingdom 8 83 0.6× 71 0.6× 15 0.2× 22 0.4× 30 0.7× 23 362
R. Mark Greenwood United Kingdom 14 31 0.2× 113 1.0× 72 1.0× 42 0.8× 37 0.8× 36 622
J Greene United States 15 9 0.1× 77 0.7× 34 0.5× 82 1.6× 41 0.9× 39 614
Michael P. O’Brien Ireland 13 25 0.2× 107 0.9× 86 1.2× 9 0.2× 13 0.3× 21 375
David Shields United States 13 9 0.1× 59 0.5× 51 0.7× 41 0.8× 7 0.2× 28 511
Ian Dickinson United Kingdom 14 14 0.1× 376 3.2× 77 1.1× 84 1.6× 30 0.7× 36 974
Houman Younessi Australia 7 15 0.1× 194 1.6× 52 0.7× 11 0.2× 50 1.1× 15 481
Fabrizio Consorti Italy 16 216 1.6× 24 0.2× 230 3.2× 238 4.7× 10 0.2× 72 941
Mark Evans United Kingdom 12 62 0.5× 202 1.7× 74 1.0× 14 0.3× 9 0.2× 20 502
Ravi Parikh United States 18 33 0.2× 23 0.2× 40 0.6× 95 1.9× 15 0.3× 81 1.2k

Countries citing papers authored by Anna Sandberg

Since Specialization
Citations

This map shows the geographic impact of Anna Sandberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Sandberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Sandberg more than expected).

Fields of papers citing papers by Anna Sandberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Sandberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Sandberg. The network helps show where Anna Sandberg may publish in the future.

Co-authorship network of co-authors of Anna Sandberg

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Sandberg. A scholar is included among the top collaborators of Anna Sandberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Sandberg. Anna Sandberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schjesvold, Fredrik, Heinz Ludwig, Sossana Delimpasi, et al.. (2024). Health-related quality of life in relapsed/refractory multiple myeloma treated with melflufen and dexamethasone: analyses from the phase III OCEAN study. Haematologica. 109(7). 2331–2336.
2.
Sandberg, Anna, et al.. (2024). Evaluation of a digital patient education programme in patients with coronary artery disease, a survey-based study. BMC Health Services Research. 24(1). 1012–1012.
3.
Bäck, Maria, Åsa Cider, Lennart Jivegård, et al.. (2023). Cost-Effectiveness of Exercise Therapy in Patients with Intermittent Claudication—A Comparison of Supervised Exercise, Home-Based Structured Exercise, and Walk Advice from the SUNFIT Trial. Journal of Clinical Medicine. 12(16). 5277–5277. 5 indexed citations
4.
5.
6.
7.
Johansen, Pierre, Barrie Chubb, Barnaby Hunt, et al.. (2020). Evaluating the Long-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Once-Daily Liraglutide for the Treatment of Type 2 Diabetes in the UK. Advances in Therapy. 37(5). 2427–2441. 19 indexed citations
8.
Sandberg, Anna, et al.. (2019). Test-retest reliability, agreement, and minimal detectable change in the 6-minute walk test in patients with intermittent claudication. Journal of Vascular Surgery. 71(1). 197–203. 21 indexed citations
9.
Jendle, Johan, et al.. (2018). A utility valuation study assessing the impact of postprandial glucose control on quality of life of individuals with type 1 or type 2 diabetes. Journal of Patient-Reported Outcomes. 2(1). 20–20. 1 indexed citations
10.
Russell‐Jones, David, Simon Heller, Sarah Buchs, et al.. (2017). Projected long‐term outcomes in patients with type 1 diabetes treated with fast‐acting insulin aspart vs conventional insulin aspart in the UK setting. Diabetes Obesity and Metabolism. 19(12). 1773–1780. 8 indexed citations
11.
Schaper, Nicolaas C., Annie Nikolajsen, Anna Sandberg, Sarah Buchs, & Mette Bøgelund. (2017). Timing of Insulin Injections, Adherence, and Glycemic Control in a Multinational Sample of People with Type 2 Diabetes: A Cross-Sectional Analysis. Diabetes Therapy. 8(6). 1319–1329. 23 indexed citations
12.
Nikolajsen, Annie, Nicolaas C. Schaper, Anna Sandberg, Sarah Buchs, & Mette Bøgelund. (2016). Timing of Insulin Injections Predicts Type 2 Diabetes Control and Adherence in a Multinational Sample. Value in Health. 19(7). A677–A677. 2 indexed citations
13.
Sandberg, Anna, Sarah Buchs, Muhammad Abdul Hadi, & Paul Swinburn. (2016). Improvements in Health-Related Quality of Life Associated with Increased Control of Postprandial Glucose Levels in Diabetes. Value in Health. 19(7). A678–A678. 2 indexed citations
14.
Staron, Miroslaw, et al.. (2014). Defining Technical Risks in Software Development. Chalmers Research (Chalmers University of Technology). 10. 66–71. 5 indexed citations
15.
Bakhai, Ameet, Anna Sandberg, Thomas Mittendorf, et al.. (2013). Patient perspective on the management of atrial fibrillation in five European countries. BMC Cardiovascular Disorders. 13(1). 108–108. 22 indexed citations
16.
17.
18.
Sandberg, Anna, et al.. (2011). PCV62 PERSISTENCE AND COMPLIANCE IN HYPERTENSION TREATMENT WITH OLMESARTAN MEDOXOMIL – ANALYSIS OF REAL-LIFE PRESCRIPTION DATA. Value in Health. 14(3). A43–A43. 2 indexed citations
19.
Breitscheidel, Lusine, et al.. (2011). Real-life treatment patterns, compliance, persistence, and medication costs in patients with hypertension in Germany. Journal of Medical Economics. 15(1). 155–165. 21 indexed citations
20.
Holmberg, Lena, et al.. (2009). Appreciating Lessons Learned. IEEE Software. 27(4). 72–79. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R.J.M. Ross Breakdown of academic impact, for papers by R. Mark Greenwood Breakdown of academic impact, for papers by J Greene Breakdown of academic impact, for papers by Michael P. O’Brien Breakdown of academic impact, for papers by David Shields Breakdown of academic impact, for papers by Ian Dickinson Breakdown of academic impact, for papers by Houman Younessi Breakdown of academic impact, for papers by Fabrizio Consorti Breakdown of academic impact, for papers by Mark Evans Breakdown of academic impact, for papers by Ravi Parikh
Rankless by CCL
2026